Cargando…

Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology

Sacubitril/valsartan (SV) has been demonstrated to reduce cardiovascular mortality, hospitalization for heart failure and to induce reverse ventricular remodeling. The present study was designed to confirm the effects of SV in a selected population of patients with HFrEF and to evaluate the differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Cemin, Roberto, Casablanca, Simona, Foco, Luisa, Schoepf, Elisabeth, Erlicher, Andrea, Di Gaetano, Renato, Ermacora, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864277/
https://www.ncbi.nlm.nih.gov/pubmed/36675549
http://dx.doi.org/10.3390/jcm12020621
_version_ 1784875543558094848
author Cemin, Roberto
Casablanca, Simona
Foco, Luisa
Schoepf, Elisabeth
Erlicher, Andrea
Di Gaetano, Renato
Ermacora, Davide
author_facet Cemin, Roberto
Casablanca, Simona
Foco, Luisa
Schoepf, Elisabeth
Erlicher, Andrea
Di Gaetano, Renato
Ermacora, Davide
author_sort Cemin, Roberto
collection PubMed
description Sacubitril/valsartan (SV) has been demonstrated to reduce cardiovascular mortality, hospitalization for heart failure and to induce reverse ventricular remodeling. The present study was designed to confirm the effects of SV in a selected population of patients with HFrEF and to evaluate the different responses between patients with an ischemic or a non-ischemic etiology. A total of 79 patients with indication of SV were recruited prospectively during a timelapse of 4 years. SV was overall associated to a reduction of end-diastolic and end-systolic volume, of NT-proBNP levels, furosemide dosage and NYHA functional class, together with an increase in EF. These changes were more evident in patients with non-ischemic dilated cardiomyopathy, who showed a significant improvement in ventricular volumes, ejection fraction, TAPSE and blood levels of NT-proBNP. Kaplan–Meier curves confirmed a greater benefit in terms of ejection-fraction improvement in non-ischemic patients compared to the ischemic group. The results of the present study confirm the positive effect of SV on NYHA functional class, NT- proBNP, left ventricular volumes and EF in HFrEF patients, showing evidence of association of SV with ventricular remodeling in patients with dilated cardiomyopathy of non-ischemic etiology compared to the ischemic group.
format Online
Article
Text
id pubmed-9864277
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98642772023-01-22 Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology Cemin, Roberto Casablanca, Simona Foco, Luisa Schoepf, Elisabeth Erlicher, Andrea Di Gaetano, Renato Ermacora, Davide J Clin Med Article Sacubitril/valsartan (SV) has been demonstrated to reduce cardiovascular mortality, hospitalization for heart failure and to induce reverse ventricular remodeling. The present study was designed to confirm the effects of SV in a selected population of patients with HFrEF and to evaluate the different responses between patients with an ischemic or a non-ischemic etiology. A total of 79 patients with indication of SV were recruited prospectively during a timelapse of 4 years. SV was overall associated to a reduction of end-diastolic and end-systolic volume, of NT-proBNP levels, furosemide dosage and NYHA functional class, together with an increase in EF. These changes were more evident in patients with non-ischemic dilated cardiomyopathy, who showed a significant improvement in ventricular volumes, ejection fraction, TAPSE and blood levels of NT-proBNP. Kaplan–Meier curves confirmed a greater benefit in terms of ejection-fraction improvement in non-ischemic patients compared to the ischemic group. The results of the present study confirm the positive effect of SV on NYHA functional class, NT- proBNP, left ventricular volumes and EF in HFrEF patients, showing evidence of association of SV with ventricular remodeling in patients with dilated cardiomyopathy of non-ischemic etiology compared to the ischemic group. MDPI 2023-01-12 /pmc/articles/PMC9864277/ /pubmed/36675549 http://dx.doi.org/10.3390/jcm12020621 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cemin, Roberto
Casablanca, Simona
Foco, Luisa
Schoepf, Elisabeth
Erlicher, Andrea
Di Gaetano, Renato
Ermacora, Davide
Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology
title Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology
title_full Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology
title_fullStr Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology
title_full_unstemmed Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology
title_short Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology
title_sort reverse remodeling and functional improvement of left ventricle in patients with chronic heart failure treated with sacubitril/valsartan: comparison between non-ischemic and ischemic etiology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864277/
https://www.ncbi.nlm.nih.gov/pubmed/36675549
http://dx.doi.org/10.3390/jcm12020621
work_keys_str_mv AT ceminroberto reverseremodelingandfunctionalimprovementofleftventricleinpatientswithchronicheartfailuretreatedwithsacubitrilvalsartancomparisonbetweennonischemicandischemicetiology
AT casablancasimona reverseremodelingandfunctionalimprovementofleftventricleinpatientswithchronicheartfailuretreatedwithsacubitrilvalsartancomparisonbetweennonischemicandischemicetiology
AT focoluisa reverseremodelingandfunctionalimprovementofleftventricleinpatientswithchronicheartfailuretreatedwithsacubitrilvalsartancomparisonbetweennonischemicandischemicetiology
AT schoepfelisabeth reverseremodelingandfunctionalimprovementofleftventricleinpatientswithchronicheartfailuretreatedwithsacubitrilvalsartancomparisonbetweennonischemicandischemicetiology
AT erlicherandrea reverseremodelingandfunctionalimprovementofleftventricleinpatientswithchronicheartfailuretreatedwithsacubitrilvalsartancomparisonbetweennonischemicandischemicetiology
AT digaetanorenato reverseremodelingandfunctionalimprovementofleftventricleinpatientswithchronicheartfailuretreatedwithsacubitrilvalsartancomparisonbetweennonischemicandischemicetiology
AT ermacoradavide reverseremodelingandfunctionalimprovementofleftventricleinpatientswithchronicheartfailuretreatedwithsacubitrilvalsartancomparisonbetweennonischemicandischemicetiology